1. 463PReal-world dosing of regorafenib (REG) in metastatic colorectal cancer (mCRC): Final results from the prospective, observational CORRELATE study. (23rd October 2018) Authors: O'Connor, J M; Ducreux, M; Petersen, L N; Öhler, L; Bergamo, F; Metges, J-P; de Groot, J W; Wang, J-Y; García Paredes, B; Dochy, E; Fiala-Buskies, S; Cervantes, A; Falcone, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗